article thumbnail

Exclusive-Big hedge funds call on doctors, scientists for an edge on pharma, sources say

Global Banking & Finance

By Nell Mackenzie LONDON (Reuters) – Some of the world’s largest hedge funds are hiring doctors, scientists and analysts to give them expert insight into the prospects for pharmaceutical stocks after big share swings in the sector, eight sources told Reuters.

Funds 52
article thumbnail

Josh Mastracci joins TM Capital as Director

TM Capital

Josh has extensive experience completing transactions across key healthcare services sectors including physician practice management, ambulatory surgery centers, and pharmaceutical services.

Capital 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Spain’s Grifols hires new CEO weeks after damaging short-seller report

Global Banking & Finance

Spain’s Grifols hires new CEO weeks after damaging short-seller report MADRID (Reuters) -Spanish pharmaceutical company Grifols hired a new chief executive and two founding family members will leave executive jobs, it said on Monday, four weeks after short-seller fund Gotham City questioned its accounting, triggering a share slump.

article thumbnail

Grifols shares tumble as Brookfield plans to drop takeover plan

Global Banking & Finance

MADRID (Reuters) -Canadian fund Brookfield is planning to drop its plan to take over Spain’s Grifols, two sources close to the matter said on Wednesday, sending shares in the pharmaceutical firm down 10%.

Shares 40
article thumbnail

Play defense with these dividend-paying stocks, says Trivariate Research's Adam Parker

CNBC: Investing

With the "old school" traditional playbook of defensive stocks like consumer staples, pharmaceuticals and telecoms is "broken," Trivariate Research has identified several ways investors can get defensive — including dividend-paying equities. Eli Lilly is the only pharmaceutical name that made the cut.

Stock 68
article thumbnail

Sterility Testing Market to Surpass 469 Million by 2030 Drives Due to Rising Demand for Quality Assurance in Pharmaceutical and Medical Industries

Global Newswire by Notified: M&A

The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. The sterility testing market is anticipated to grow substantially owing to the increasing investments and funding. over the forecast period (2023-2030). over the forecast period (2023-2030).

article thumbnail

01-26-2024 Newsletter: When You Need to Return Cash in order to Raise More

OfficeHours

This slowdown in sales has negatively impacted firms’ ability to raise money from investors, which have become reluctant to commit to new funds before seeing returns from previous vehicles. They need to invest remaining capital and go back to the market to raise new funds, which means a need to drive exits and improve distributions.”